LOS ANGELES, Sept. 4, 2019 /PRNewswire/ -- For the first time in American history, U.S. landmarks in all 50 states (and the District of Columbia) were lit blue on September 3 to kick-off Prostate Cancer Awareness Month. The Prostate Cancer Foundation's (PCF) "Light It Blue" campaign is a national effort

WEST ORANGE, N.J., Sept. 4, 2019 /PRNewswire/ -- Parents place their faith in the education system for not only learning but also for nurturing and development of their children. The role of teachers in shaping America's future cannot be overestimated. "Teachers are under increasing stress and are not immune from turning to alcohol or drugs in order to cope with stressor

NASDAQ, TSX: NVCN VANCOUVER, Sept. 4, 2019 /PRNewswire/ - Neovasc, Inc. ("Neovasc" or the "Company") (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that

STOCKHOLM, Sept. 4, 2019 /PRNewswire/ --  Cyxone (publ), a Swedish biotechnology company in autoimmune diseases, today announced that the company's board of directors has decided to explore the possibilities of an orphan drug designation (ODD) of the drug candidate Rabeximod. An orphan drug status would mean that the drug candidate obtains a strengthened position

MENLO PARK, Calif., Sept. 4, 2019 /PRNewswire/ -- Sight Sciences, Inc., a growth-stage medical device company transforming the two fastest growing segments in ophthalmology and optometry, glaucoma and dry eye disease, today announced the closing of $31 million in Series D Preferred Stock financing led by KCK Group, a leading investor in high

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Research Foundation to Cure AIDS (RFTCA) has obtained a worldwide license to biotechnology known as Chromovert® Technology, to research, develop and commercialize a cure for HIV/AIDS. This is the first and only case of an IRS Code § 501(c)3 not-for-profit organizati

SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Tivic Health™ Systems Inc., a commercial phase bioelectronic company, will be exhibiting ClearUP® Sinus Pain Relief,

SALEM, N.H., Sept. 4, 2019 /PRNewswire/ -- Summit Diagnostics, the leader in innovative testing, now offers a new Validity Screen which now proves that the specimens being tested are real, unadulterated and not replaced with synthetics.  The US Drug Enforcement Agency (DEA) states that as much as 10 percent of all drug test samples have been adulterated, swit

DENVER, Sept. 4, 2019 /PRNewswire/ -- SCB Global Healthcare Services, LLC, a Denver based healthcare services holding company founded by Warren Olsen and Russ Matthews today announced that it has acquired the Gallus Detox Centers, a provider of customized inpatient medical deto

NEW YORK, Sept. 4, 2019 /PRNewswire/ -- Capital Rx (https://cap-rx.com), a next generation pharmacy benefits manager, announced today the launch of its Clearinghouse Model,